Skip to content

FLEXPHARMA

Active Risk: not assessed
Private limited companyfounded 2026active for less than a yearRue de l'Eglise, Harre 19, 6960 Manhay, BelgiumKBO/BCE: BE 1034.325.846
Summary

FLEXPHARMA is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
No accounts filed yet
Financial health
No score: no figuresToo young for a bankruptcy probability
Signalsraises riskYoung companyShow the evidence

Signals

1 signal.
raises risk
raises risk · Young company
Founded in 2026, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years under a year 0 10 years
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2026.
KBO publications · our coverage
  1. IncorporationAppointment: GUIOT Françoise Monique Michèle…

Financials

First annual accounts expected by 31-07-2027
The first financial year runs to 31-12-2026. No annual accounts are due yet, so no filing is missing.

Similar companies · same sector and region

No filed accounts are known for this company, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,205 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,896. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2026
GUIOT Françoise Monique Michèle Claire Marthe
Director (not named in the articles) · since 16-02-2026
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2026, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
GUIOT Françoise Monique Michèle Claire Marthe
  • Director (not named in the articles), from 16-02-2026 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 16-02-2026 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 16-02-2026 Incorporation · €2,000 · 100 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 12 February 2026, FLEXPHARMA was incorporated as a private limited company by one natural person, with a starting capital of €2,000.12 GUIOT Françoise Monique Michèle Claire Marthe has served as director of the company since 2026.2

  1. 1KBO register
  2. 2Belgian Official Gazette, 16-02-2026

Acts, filings and financial milestones

2026
16-02
Gazette deed Incorporation
Appointment: GUIOT Françoise Monique Michèle Claire Marthe (director) · Founder · Founding capital8 facts ▸
  • Incorporation, 12-02-2026
  • Founder, GUIOT Françoise Monique Michèle Claire Marthe
  • Founding capital, €2,000
  • Capital
  • Registered office clause, “6960 Manhay, rue de l'Eglise”, 19 (deed in French)
  • Other provision, “Néant, Néant” (deed in French)
  • Director appointment, GUIOT Françoise Monique Michèle Claire Marthe (director (not named in the articles))
  • Pre-incorporation commitments, FLEXPHARMA
Gazette deed
1 of 1 deed read

Register details

Identification
Legal formPrivate limited company
Founded12-02-2026
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:1034325846
Also 9925:BE1034325846
Registered 22-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 October 2026 · Peppol Directory

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Manhay · 1 establishment unit since 2026
registered office establishment The establishment unit on the map
Ground area
535 m²
Building footprint
240 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
FLEXPHARMA
Rue du Centre 71, 4130 EsneuxRetail sale of pharmaceutical products
since 2026unit no. 2.385.647.197
2 parcels
Wallonia 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
83023A0914/02G000 Wallonia 396 m² 1 · 147 m² -
62032A0293/00R007 Wallonia 139 m² 1 · 93 m² -
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Toutes opérations et activités se rattachant directement ou indirectement aux activités suivantes : l’achat, la vente, la prise en location…” (deed in French)
12 activities (deed in French)
  1. Toutes opérations et activités se rattachant directement ou indirectement aux activités suivantes : l’achat, la vente, la prise en location, l’exploitation sous quelque forme que ce soit, et la location d’officines pharmaceutiques.
  2. La prestation de service en pharmacie
  3. La formation et l’organisation de cours en toutes matières relatives à la pharmacie.
  4. La vente en gros ou au détail de tous produits se rapportant ou non à ces activités.
  5. L’activité d’import-export de tous produits se rapportant ou non à ces activités.
  6. Le conseil dans les domaines pharmaceutique, scientifique, technique, alimentaire, au sens large du terme.
  7. La recherche et développement, la promotion, l’achat et la vente de tous produits médicaux, pharmaceutiques, thérapeutiques, cosmétiques, diététiques, à usage humain, végétal, animal, biologiques, produits chimiques, de tous matériels et instruments médicaux et chirurgicaux. La société peut rendre des services de soutien à des tiers et en particulier, à des sociétés liées.
  8. De manière générale, la société peut, sans que cette énumération soit limitative, acquérir, aliéner, prendre ou donner en location tous immeubles ou fonds de commerce, acquérir, créer tous brevets, licences, marques de fabrique ou de commerce, s’intéresser de toutes les manières, sous toutes les formes et en tous lieux, à toutes sociétés ou entreprises, affaires, associations, institutions dont l’objet social serait similaire, analogue ou connexe au sien, ou simplement utile à l’extension de ses opérations ou à la réalisation de tout ou partie de son objet social.
  9. Dans le cadre de la réalisation des objets qui précèdent, la société peut également prêter de l’argent, à intérêts ou non, donner caution tant pour ses propres engagements que pour les engagements de tiers, entre autres en donnant ses biens en hypothèque ou en gage, y compris son propre fonds de commerce.
  10. Elle peut faire, en Belgique et à l’étranger, d’une façon générale, toutes opérations commerciales, industrielles, financières, mobilières ou immobilières, se rapportant directement ou indirectement à son objet ou pouvant le favoriser.
  11. Elle peut effectuer tous placements en valeurs mobilières et immobilières et les gérer, s’intéresser par voie d’association, d’apport ou de fusion, de souscription, de participation, d’intervention financière ou de toutes autres manières, dans toutes sociétés, associations ou entreprises, existantes ou à créer, et conférer toutes sûretés pour comptes de tiers.
  12. La société peut être administrateur, ou liquidateur d'autres sociétés ou entreprises.

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
FLEXPHARMA
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Région wallonne, n’entraîne pas de changement en matière de régime linguistique applicable à la société” (deed in French)

deed of 16-02-2026

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
2 provisions in the deed

deed of 16-02-2026

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Nominatives, Les titulaires d’actions peuvent prendre connaissance de ce registre relatif à leurs titres” (deed in French)
1 more provision on this in the deed
Profit allocationHow profit is distributed; a BV may only pay out after a balance-sheet and liquidity test.
One provision in the deed

deed of 16-02-2026

Meetings and financial year

Financial yearThe twelve-month period the company draws up its annual accounts for.
From 1 January to 31 December
First financial yearThe first financial year after incorporation can be shorter or longer than twelve months.
First financial year to 31-12-2026, first annual accounts due by 31-07-2027
Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Last Friday of June at 18:00

deed of 16-02-2026

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
Auditor ruleHow a statutory auditor is appointed and what they check, if the company has one.
One provision in the deed
Dissolution ruleWhen and by whom the company can be dissolved.
One provision in the deed
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
One provision in the deed

deed of 16-02-2026

Other provisionsOther rules from the articles that fall under none of the themes above.

2 more provisions in the deed, see the deed of 16-02-2026

deed of 16-02-2026